Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial

Daniel Gaudet, S van Deventer, Valerie Sier-Ferreira et al.|Gene Therapy|2012

Cited by 399